Over the last 7 days, the Life Sciences industry has risen 7.5%, driven by gains from WuXi Biologics (Cayman) of 6.8%. This takes the industry's 12 month performance to a gain of 95%. Looking forward, earnings are forecast to grow by 33% annually.
Has the Hong Kong Life Sciences Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Tue, 15 Jul 2025 | HK$240.4b | HK$37.3b | HK$2.7b | 49.5x | 87.6x | 6.5x |
Thu, 12 Jun 2025 | HK$229.6b | HK$36.2b | HK$2.6b | 29.6x | 88.1x | 6.3x |
Sat, 10 May 2025 | HK$188.7b | HK$35.7b | HK$2.6b | 26x | 73.7x | 5.3x |
Mon, 07 Apr 2025 | HK$207.7b | HK$35.5b | HK$2.5b | 28.4x | 81.7x | 5.9x |
Wed, 05 Mar 2025 | HK$186.1b | HK$35.8b | -HK$1,057,881,585.18 | 46.1x | -175.9x | 5.2x |
Fri, 31 Jan 2025 | HK$157.0b | HK$36.0b | -HK$1,059,490,952.13 | 52.3x | -148.2x | 4.4x |
Sun, 29 Dec 2024 | HK$158.3b | HK$35.6b | -HK$1,057,434,619.59 | 58.3x | -149.7x | 4.4x |
Tue, 26 Nov 2024 | HK$132.4b | HK$35.9b | -HK$1,057,923,585.61 | 46.5x | -125.2x | 3.7x |
Thu, 24 Oct 2024 | HK$162.0b | HK$35.7b | -HK$660,780,589.73 | 29x | -245.2x | 4.5x |
Sat, 21 Sep 2024 | HK$153.6b | HK$36.0b | -HK$655,634,364.33 | 26.4x | -234.3x | 4.3x |
Mon, 19 Aug 2024 | HK$101.9b | HK$35.0b | HK$2.5b | 18x | 41x | 2.9x |
Wed, 17 Jul 2024 | HK$92.9b | HK$33.4b | HK$3.1b | 19.7x | 30.2x | 2.8x |
Fri, 14 Jun 2024 | HK$95.6b | HK$33.5b | HK$3.1b | 24.7x | 31x | 2.9x |
Sun, 12 May 2024 | HK$114.5b | HK$33.6b | HK$3.1b | 29.5x | 37x | 3.4x |
Tue, 09 Apr 2024 | HK$112.2b | HK$33.6b | HK$3.1b | 33x | 36.2x | 3.3x |
Thu, 07 Mar 2024 | HK$155.5b | HK$32.3b | HK$3.0b | 65.1x | 52.3x | 4.8x |
Sat, 03 Feb 2024 | HK$124.4b | HK$32.6b | HK$3.0b | 52.1x | 41.1x | 3.8x |
Mon, 01 Jan 2024 | HK$212.8b | HK$32.6b | HK$3.0b | 90.4x | 70.3x | 6.5x |
Wed, 29 Nov 2023 | HK$285.4b | HK$32.3b | HK$3.0b | 88.1x | 95.4x | 8.8x |
Fri, 27 Oct 2023 | HK$238.5b | HK$30.1b | HK$2.7b | 42.6x | 89.6x | 7.9x |
Sun, 24 Sep 2023 | HK$230.6b | HK$30.1b | HK$2.7b | 40.7x | 86.3x | 7.7x |
Tue, 22 Aug 2023 | HK$216.6b | HK$28.2b | HK$2.7b | 23.5x | 80.5x | 7.7x |
Thu, 20 Jul 2023 | HK$213.6b | HK$28.3b | HK$2.7b | 22.2x | 78.8x | 7.5x |
Sat, 17 Jun 2023 | HK$251.8b | HK$28.7b | HK$2.8b | 22.8x | 90.6x | 8.8x |
Mon, 15 May 2023 | HK$243.5b | HK$29.3b | HK$2.9b | 22x | 84.2x | 8.3x |
Wed, 12 Apr 2023 | HK$258.3b | HK$29.6b | HK$3.0b | 17.3x | 86.4x | 8.7x |
Fri, 10 Mar 2023 | HK$275.9b | HK$26.1b | HK$2.0b | 25.1x | 137.7x | 10.6x |
Sun, 05 Feb 2023 | HK$347.5b | HK$26.7b | HK$2.1b | 29.6x | 162.2x | 13x |
Tue, 03 Jan 2023 | HK$315.8b | HK$26.2b | HK$2.0b | 26.5x | 154.7x | 12.1x |
Thu, 01 Dec 2022 | HK$262.6b | HK$25.5b | HK$1.9b | 26.3x | 140.8x | 10.3x |
Sat, 29 Oct 2022 | HK$212.4b | HK$25.4b | HK$1.8b | 19.3x | 115.9x | 8.4x |
Mon, 26 Sep 2022 | HK$242.9b | HK$25.7b | HK$1.9b | 21x | 128x | 9.4x |
Wed, 24 Aug 2022 | HK$346.8b | HK$25.2b | HK$2.8b | 10.7x | 125.1x | 13.7x |
Fri, 22 Jul 2022 | HK$419.4b | HK$22.3b | HK$2.0b | 12.9x | 206.1x | 18.8x |
206.1x
Which industries have driven the changes within the Hong Kong Healthcare industry?
HK Market | 1.79% | |
Healthcare | 3.58% | |
Life Sciences | 7.54% | |
Clinical Research and Equipment | 7.54% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
2269 WuXi Biologics (Cayman) | HK$26.75 | 6.8% +HK$6.9b | 141.4% | PE29.6x | |
2268 WuXi XDC Cayman | HK$48.15 | 10.7% +HK$5.6b | 211.0% | PE49.5x | |
2228 XtalPi Holdings | HK$5.79 | 8.2% +HK$1.8b | -0.2% | PS79.8x | |
1548 Genscript Biotech | HK$15.18 | 3.7% +HK$1.2b | 21.1% | PS7.1x | |
3880 Medtide | HK$36.95 | 17.3% +HK$772.8m | n/a | PE80.9x |